Chikungunya vaccine VLA1553 induces sustained protective antibody concentrations

Ernesto T A Marques1, Rafael Dhalia2

  • 1Department of Virology and Experimental Therapeutics, Instituto Aggeu Magalhães, Fundação Oswaldo Cruz - FIOCRUZ, Recife, Brazil; Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, 1526 PA, USA.

Abstract

No abstract available in PubMed .